Polymicrogyria associated with 17p13.3p13.2 duplication: Case report and review of the literature.

Eur J Med Genet

Murdoch Children's Research Institute, Parkville, Victoria, Australia; Royal Children's Hospital Melbourne, Parkville, Victoria, Australia; Department of Paediatrics, University of Melbourne, Australia.

Published: April 2020


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

We present the case of a male infant with bilateral perisylvian polymicrogyria associated with a de novo duplication of chromosome region 17p13.3p13.2. To our knowledge, this is the first report of polymicrogyria associated with the 17p13.3 contiguous gene duplication syndrome. Testing for known monogenic causes of polymicrogyria was negative and there was no clinical evidence of an acquired prenatal cause. Given the critical, dose-sensitive role that the 17p13.3 region plays in brain development, we suggest that the chromosome duplication is the most likely explanation for the polymicrogyria. Clinical and functional studies have demonstrated deleterious effects of increased LIS1 expression on the developing brain and the contribution of YWHAE to the brain phenotype of the 17p13 duplication syndrome. There is also evidence that CRK, the other candidate gene in this region, via interaction with LIS1, plays a critical role in cortical development. In addition to LIS1, YWHAE and CRK, our patient's chromosome duplication involves at least 100 other genes, less than half of which are annotated at the time of writing. It is expected that the ongoing use of chromosome microarray and next-generation sequencing to investigate the genetic causes of brain malformations will continue to extend our understanding of the 17p13 region and of the contributions of the genes in this region to cortical development.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejmg.2019.103774DOI Listing

Publication Analysis

Top Keywords

polymicrogyria associated
12
duplication syndrome
8
chromosome duplication
8
cortical development
8
duplication
6
polymicrogyria
5
region
5
associated 17p133p132
4
17p133p132 duplication
4
duplication case
4

Similar Publications

Cortical malformations, including microgyria, are often associated with neurodevelopmental comorbidities such as epilepsy and cognitive impairments in humans. To investigate how early cortical disruption leads to persistent behavioral impairments, we employed a neonatal neocortical focal freeze lesion (FFL) model of polymicrogyria in male Wistar rats. Unilateral cortical lesions were induced at postnatal day 0 (P0), and molecular changes in hippocampal gene expression (glutamatergic signaling: Grin1, Grin2a, Grin2b, Gria1, Gria2; neuroinflammation: Nlrp3, Il1b, Il1rn; glial markers: Gfap, Aif1; neurotrophic factors: Bdnf, Fgf2) were analyzed at P21.

View Article and Find Full Text PDF

MAP1B (microtubule-associated protein 1B) encodes a cytoskeletal regulator critical for neuronal migration, axon guidance, and cortical circuit formation. Disease-causing variants (DCVs) in MAP1B have recently emerged as a cause of neurodevelopmental disorders characterized by intellectual disability, epilepsy, and cortical malformations, including periventricular nodular heterotopia (PVNH) and polymicrogyria (PMG). However, the phenotypic and neuroimaging spectrum associated with MAP1B-related disease remains incompletely defined.

View Article and Find Full Text PDF

Modeling MPPH syndrome in vivo using Breasi-CRISPR.

HGG Adv

August 2025

Pediatrics and Rare Diseases Group, Sanford Research, Sioux Falls, SD 57104, USA; Sanford School of Medicine, University of South Dakota, Sioux Falls, SD 57105, USA. Electronic address:

The increasing availability and affordability of genetic testing has resulted in the identification of numerous novel variants associated with neurodevelopmental disorders. There remains a need for methods to analyze the functional impact of these variants. Some methods, like expressing these variants in cell culture, may be rapid, but they lack physiologic context.

View Article and Find Full Text PDF

A Report of Dual Presentations of Pseudo-TORCH Syndrome 1 and MCC2 Deficiency and Review of the Literature.

Mol Syndromol

August 2025

Myelin Disorders Clinic, Department of Pediatric Neurology, Children's Medical Center, Pediatrics Center of Excellence, Tehran University of Medical Sciences, Tehran, Iran.

Introduction: Pseudo-TORCH syndrome, named as such due to the mimicry of intrauterine TORCH infections in the absence of infection, is a neurological disorder presenting primarily with congenital microcephaly, intracranial calcifications, simplified gyration and polymicrogyria, and severe developmental delay, which can be attributed to variants in the gene. MCC2 deficiency, a neurometabolic disorder due to impairments in the catabolism of Leucine, with highly variable clinical presentations in addition to landmark metabolic features is put down to variants in gene.

Case Presentation: Known as independent conditions, the intriguing presence of dual manifestations in a 3.

View Article and Find Full Text PDF

Epilepsy Secondary to Polymicrogyria.

J Community Hosp Intern Med Perspect

July 2025

Department of Internal Medicine, MedStar Harbor Hospital, Baltimore, USA.

We present the case of a young man in his early thirties who sought medical attention after a witnessed seizure episode. His drug screen revealed the presence of cocaine, marijuana, and benzodiazepines. To investigate any potential structural causes contributing to his seizure, we conducted an MRI of the brain, which revealed polymicrogyria.

View Article and Find Full Text PDF